Astec Lifesciences (NSE:ASTEC) NonCurrent Deferred Liabilities: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
76 GF Score
Price ₹682.45
GF Value ₹990.82
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences NonCurrent Deferred Liabilities?

Astec Lifesciences NSE:ASTEC -0.61% 76 NonCurrent Deferred Liabilities is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:ASTEC with a GF Score™ of 76/100 and a GF Value™ of ₹990.82 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Astec Lifesciences's non-current deferred liabilities for the quarter that ended in Mar. 2026 was ₹0 Mil.

Astec Lifesciences NonCurrent Deferred Liabilities Related Terms

Astec Lifesciences NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences NonCurrent Deferred Liabilities Chart

Astec Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Astec Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:ASTEC
76GF Score
Astec Lifesciences Ltd NSE:ASTEC
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of ₹0 Mil mean?
Astec Lifesciences (NSE:ASTEC) has a NonCurrent Deferred Liabilities of ₹0 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Astec Lifesciences and its competitors.
Is Astec Lifesciences' NonCurrent Deferred Liabilities too high?
Astec Lifesciences' current NonCurrent Deferred Liabilities is ₹0 Mil. Overall, Astec Lifesciences has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' NonCurrent Deferred Liabilities compare to CTVA and CF?
Astec Lifesciences' NonCurrent Deferred Liabilities of ₹0 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for an Agriculture company?
A good NonCurrent Deferred Liabilities depends on the Agriculture industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Astec Lifesciences and its competitors. Astec Lifesciences's current NonCurrent Deferred Liabilities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹990.82, compared to a current price of ₹682.45 — trading 31.1% below its estimated fair value. The current NonCurrent Deferred Liabilities is ₹0 Mil. Astec Lifesciences' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current NonCurrent Deferred Liabilities is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹682.45 is trading 31.1% below its estimated GF Value™ of ₹990.82. GuruFocus considers Astec Lifesciences to be Significantly Undervalued.

Key valuation signals for NSE:ASTEC:

  • NonCurrent Deferred Liabilities: ₹0 Mil
  • GF Value™: ₹990.82 vs. price of ₹682.45 (31.1% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
76GF Score

Get the complete analysis for NSE:ASTEC

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹682.45
Price
₹990.82
GF Value